Karl-Ludwig Kley Receives Weizmann Award in the Sciences and Humanities
Darmstadt, Germany, and Rehovot, Israel, February 16, 2016 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced
that the Weizmann Institute, Rehovot, Israel, conferred the renowned Weizmann Award in the Sciences and Humanities on Karl-Ludwig Kley, CEO and Chairman of the Executive Board of Merck KGaA, Darmstadt, Germany.
“It is particularly important to us to acknowledge and honor your support and friendship with Israel and with the Weizmann Institute of Science,” Daniel Zajfman, President of the Weizmann Institute, said when conferring the Weizmann Award in
the Sciences and Humanities to Kley Monday evening. “Throughout your career, you have expressed support and encouragement for Israel science and scientists; have been an exceptional friend to the Weizmann Institute; and have spearheaded and advanced the technology transfer relationship between the Institute and your company with the goal of improving the lives of many people through better medical therapies.”
“Over the past 10 years, my affection, empathy and friendship have grown with Israel and with the Weizmann Institute. I know that I am not only receiving an award from partners, but from friends,” Kley said in his speech after the award.
“This award will also contribute to further deepening the institutional relationship between the Weizmann Institute and our company. During the past years we have created a very special bond between us and the Weizmann Institute. It will live on.”
Since 1966, the Weizmann Award in the Sciences and Humanities has been granted
to a small, distinguished group of world leaders and scientists whom the Weizmann
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Merck KGaA, Darmstadt, Germany, has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.